Literature DB >> 17316083

A panel of monoclonal antibodies recognizing the Staphylococcus epidermidis fibrinogen-binding MSCRAMM SdrG.

Andrea E Hall1, Pratiksha R Patel, Paul J Domanski, Bradley D Prater, Elena L Gorovits, Peter J Syribeys, John H Vernachio, Joseph M Patti, Jeff T Hutchins.   

Abstract

Staphylococcus epidermidis is an important opportunistic human pathogen that has recently emerged as a major cause of foreign-body infections. The most important stage contributing to the pathogenesis of this bacteria is the initial adherence to host tissue. SdrG is a cell-wall-anchored fibrinogen-binding adhesin of S. epidermidis that has been shown to be necessary for bacterial binding to fibrinogen-coated foreign bodies, such as catheters. Here we report the generation and characterization of a panel of monoclonal antibodies (MAbs) directed against this S. epidermidis virulence factor. Through the use of multiple in vitro assays, surface plasmon resonance, and flow cytometry, we have characterized a diverse array of MAbs that may prove to be beneficial in studies that address the precise biologic role of SdrG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316083     DOI: 10.1089/hyb.2006.039

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  3 in total

1.  Expression of Staphylococcus epidermidis SdrG increases following exposure to an in vivo environment.

Authors:  Bret R Sellman; Yekaterina Timofeyeva; Jasdeep Nanra; Adrienne Scott; James P Fulginiti; Yury V Matsuka; Steve M Baker
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

Review 2.  Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens.

Authors:  Yamilé López Hernández; Daniel Yero; Juan M Pinos-Rodríguez; Isidre Gibert
Journal:  Front Microbiol       Date:  2015-02-04       Impact factor: 5.640

Review 3.  Monoclonal Antibodies Targeting Surface-Exposed and Secreted Proteins from Staphylococci.

Authors:  Pietro Speziale; Giampiero Pietrocola
Journal:  Vaccines (Basel)       Date:  2021-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.